Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SoftOx Solutions AS Share Issue/Capital Change 2024

Sep 18, 2024

3747_rns_2024-09-18_6fb96cd6-3589-4843-b588-938a016e77d3.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

SoftOx Solution AS: New Share Capital

SoftOx Solution AS: New Share Capital

Reference is made to the stock exchange release from SoftOx Solutions AS (the "Company") on 17th of September 2024 regarding the board resolution to increase the share capital by converting outstanding claims to new shares in the Company.

The new share capital following the completion of the share capital increase has today been registered with the Norwegian Register of Business Enterprises.

The new share capital of the Company is NOK 39 025 078,84 divided into 1 951 253 942 shares, each with a par value of NOK 0,02.

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx) is a Medtech and pharmaceutical company listed on Euronext Growth Oslo under 'SOFTX'. SoftOx Solutions AS was founded in 2012 and is headquartered in Oslo. The SoftOx Solutions Group includes the holding company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AB (WIAB), and subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx is developing a highly effective antimicrobial solution for use in biofilm, viral, and antimicrobial-resistant infections. The patent-protected technology is based on extensive research and development in partnership with leading Nordic research institutes.

For more information on SoftOx, visit www.soft-ox.com